Asking questions to avoid Type 2 Diabetes

A new study presented at this year’s American Diabetes Association’s 71st Annual Scientific Sessions suggests a simple way for doctors to help people who may be at risk of developing type 2 diabetes.

The SHIELD study (The Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes) showed that patients with risk factors related to their age, family history, and obesity significantly increase their risk of transition to type 2 diabetes by as much as 300 to 500 percent. Doctors who understand pre-diabetes risk factors and ask the right questions of their patients can quickly identify at-risk patients before they develop the disease, the study suggests.

SHIELD Risk Predictors Graphic-FINAL-Compliance Copy-6.17.11

The SHIELD study is the largest nongovernmental study of its kind and was sponsored by AstraZeneca. SHIELD was a population-based survey conducted from 2004 to 2009 to better understand the risk for the development of diabetes mellitus, as well as disease burden.

“This collection of patient self-reported data has given us valuable real-world evidence of how doctors can help patients manage their risks of developing type 2 diabetes,” said Susan Grandy, PhD, Value Demonstration Leader and SHIELD Study Director, Health Economics & Outcomes Research at AstraZeneca.

Diabetes affects 25.6 million adults in the United States, or 11.3 percent of the total adult population. Type 2 diabetes accounts for approximately 90 to 95 percent of all cases of diagnosed diabetes in adults.

To read more about the specific findings of SHIELD, click here.

-By Corey Windett, Senior Manager for Brand Corporate Affairs at AstraZeneca